SCHEMBL4036125

SCHEMBL4036125

Clc1ccc2nc(Nc3c(Cl)cccc3Cl)c3cncn3c2n1

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.67
SRC P12931 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4039987 0.92 LCK (0.71) LCKSRC
SCHEMBL4036268 0.85 LCK (0.61) LCKSRC
SCHEMBL7982128 0.81 LCK (1.00) LCK
SCHEMBL4043066 0.81 LCK (0.69) LCKSRC
SCHEMBL4039577 0.81 LCK (0.64) LCKSRC
SCHEMBL4036151 0.81 LCK (0.62) LCKSRC
SCHEMBL4040959 0.79 LCK (0.69) LCKSRC
SCHEMBL4041705 0.79 LCK (0.69) LCKSRC
SCHEMBL4036402 0.78 LCK (0.67) LCKSRC
SCHEMBL4036450 0.78 LCK (0.74) LCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP claimed
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP disclosed